Provided by Tiger Trade Technology Pte. Ltd.

Allena Pharmaceuticals Inc.

0.0750
0.0000
Volume:- -
Turnover:- -
Market Cap:9.16M
PE:-0.15
High:0.0750
Open:0.0750
Low:0.0750
Close:0.0750
52wk High:0.0750
52wk Low:0.0750
Shares:122.08M
Float Shares:120.96M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4964
EPS(LYR):-0.7161
ROE:-541.02%
ROA:-106.64%
PB:2.45
PE(LYR):-0.10

Loading ...

Company Profile

Company Name:
Allena Pharmaceuticals Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic kidney diseases. Allena Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Newton, Massachusetts.